- Home
- TELA vs INMB Comparison
TELA vs INMB Comparison
Compare TELA & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- INMB
- Stock Information
- Founded
- TELA 2012
- INMB 2015
- Country
- TELA United States
- INMB United States
- Employees
- TELA N/A
- INMB N/A
- Industry
- TELA Medical/Dental Instruments
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TELA Health Care
- INMB Health Care
- Exchange
- TELA Nasdaq
- INMB Nasdaq
- Market Cap
- TELA 60.6M
- INMB 49.2M
- IPO Year
- TELA 2019
- INMB 2019
- Fundamental
- Price
- TELA $1.29
- INMB $1.72
- Analyst Decision
- TELA Buy
- INMB Hold
- Analyst Count
- TELA 3
- INMB 3
- Target Price
- TELA $5.33
- INMB $4.30
- AVG Volume (30 Days)
- TELA 96.8K
- INMB 330.5K
- Earning Date
- TELA 11-13-2025
- INMB 10-30-2025
- Dividend Yield
- TELA N/A
- INMB N/A
- EPS Growth
- TELA N/A
- INMB N/A
- EPS
- TELA N/A
- INMB N/A
- Revenue
- TELA $75,323,000.00
- INMB $50,000.00
- Revenue This Year
- TELA $25.72
- INMB $264.29
- Revenue Next Year
- TELA $22.03
- INMB $9,819.61
- P/E Ratio
- TELA N/A
- INMB N/A
- Revenue Growth
- TELA 16.34
- INMB 19.05
- 52 Week Low
- TELA $0.86
- INMB $1.71
- 52 Week High
- TELA $3.26
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- TELA 35.65
- INMB 38.92
- Support Level
- TELA $1.13
- INMB $1.73
- Resistance Level
- TELA $1.51
- INMB $1.93
- Average True Range (ATR)
- TELA 0.09
- INMB 0.10
- MACD
- TELA -0.02
- INMB -0.00
- Stochastic Oscillator
- TELA 37.21
- INMB 3.45
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.